Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Crossroads in the combined-modality management of gastroesophageal junction carcinomas.

Apisarnthanarax S, Tepper JE.

Gastrointest Cancer Res. 2008 Sep;2(5):235-43.

2.
3.

What's the Best Way to Treat GE Junction Tumors? Approach Like Gastric Cancer.

Mullen JT, Kwak EL, Hong TS.

Ann Surg Oncol. 2016 Nov;23(12):3780-3785. Epub 2016 Jul 26. Review.

PMID:
27459983
4.

Clinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approach.

Cellini F, Morganti AG, Di Matteo FM, Mattiucci GC, Valentini V.

Radiat Oncol. 2014 Feb 5;9:45. doi: 10.1186/1748-717X-9-45. Review.

5.

Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and the gastro-esophageal junction.

van de Ven C, De Leyn P, Coosemans W, Van Raemdonck D, Lerut T.

Eur J Cardiothorac Surg. 1999 Jun;15(6):769-73.

PMID:
10431857
6.
7.

Comparative effectiveness in esophagogastric cancer.

Knab LM, Belotte J, Munshi HG, Bentrem DJ.

Cancer Treat Res. 2015;164:121-42. doi: 10.1007/978-3-319-12553-4_8.

PMID:
25677022
8.

Clinicopathologic features and treatment outcomes of patients with human epidermal growth factor receptor 2-positive adenocarcinoma of the esophagus and gastroesophageal junction.

Phillips BE, Tubbs RR, Rice TW, Rybicki LA, Plesec T, Rodriguez CP, Videtic GM, Saxton JP, Ives DI, Adelstein DJ.

Dis Esophagus. 2013 Apr;26(3):299-304. doi: 10.1111/j.1442-2050.2012.01369.x. Epub 2012 Jun 7.

PMID:
22676551
9.

Impact of the 7th Edition AJCC staging classification on the NCCN clinical practice guidelines in oncology for gastric and esophageal cancers.

Strong VE, D'Amico TA, Kleinberg L, Ajani J.

J Natl Compr Canc Netw. 2013 Jan 1;11(1):60-6. Review.

PMID:
23307982
10.

Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus.

Ronellenfitsch U, Schwarzbach M, Hofheinz R, Kienle P, Kieser M, Slanger TE, Jensen K; GE Adenocarcinoma Meta‚Äźanalysis Group.

Cochrane Database Syst Rev. 2013 May 31;(5):CD008107. doi: 10.1002/14651858.CD008107.pub2. Review.

PMID:
23728671
11.

Preoperative and adjuvant therapies for upper gastrointestinal cancers.

Varadhachary G, Ajani JA.

Expert Rev Anticancer Ther. 2005 Aug;5(4):719-25. Review.

PMID:
16111471
12.

Multidisciplinary management of gastric and gastroesophageal cancers.

Moehler M, Lyros O, Gockel I, Galle PR, Lang H.

World J Gastroenterol. 2008 Jun 28;14(24):3773-80. Review.

13.

Comparison of locoregional versus extended locoregional radiation volumes for patients with nonmetastatic gastro-esophageal junction carcinomas.

Wang J, Milton DR, He L, Komaki R, Liao Z, Crane CH, Minsky BD, Thall PF, Lin SH.

J Thorac Oncol. 2015 Mar;10(3):518-26. doi: 10.1097/JTO.0000000000000457.

14.

Neoadjuvant vs. adjuvant treatment of Siewert type II gastroesophageal junction cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.

Miccio JA, Oladeru OT, Yang J, Xue Y, Choi M, Zhang Y, Yoon H, Ryu S, Stessin AM.

J Gastrointest Oncol. 2016 Jun;7(3):403-10. doi: 10.21037/jgo.2015.10.06.

15.

Combined modality therapy of localized gastric and esophageal cancers.

Das P, Fukami N, Ajani JA.

J Natl Compr Canc Netw. 2006 Apr;4(4):375-82. Review.

PMID:
16569390
16.

Individualized surgical strategies for cancer of the esophagogastric junction.

Stein HJ, Feith M, Siewert JR.

Ann Chir Gynaecol. 2000;89(3):191-8. Review.

PMID:
11079787
17.

A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction.

Ajani JA, Komaki R, Putnam JB, Walsh G, Nesbitt J, Pisters PW, Lynch PM, Vaporciyan A, Smythe R, Lahoti S, Raijman I, Swisher S, Martin FD, Roth JA.

Cancer. 2001 Jul 15;92(2):279-86.

PMID:
11466680
19.

A phase II trial of induction epirubicin, oxaliplatin, and fluorouracil, followed by surgery and postoperative concurrent cisplatin and fluorouracil chemoradiotherapy in patients with locoregionally advanced adenocarcinoma of the esophagus and gastroesophageal junction.

McNamara MJ, Adelstein DJ, Bodmann JW, Greskovich JF Jr, Ives DI, Mason DP, Murthy SC, Rice TW, Saxton JP, Sohal D, Stephans K, Rodriguez CP, Videtic GM, Rybicki LA.

J Thorac Oncol. 2014 Oct;9(10):1561-7. doi: 10.1097/JTO.0000000000000312.

20.

The Role of Radiotherapy in Localized Esophageal and Gastric Cancer.

Ng J, Lee P.

Hematol Oncol Clin North Am. 2017 Jun;31(3):453-468. doi: 10.1016/j.hoc.2017.01.005. Epub 2017 Mar 22. Review.

PMID:
28501087

Supplemental Content

Support Center